tiprankstipranks
Advertisement
Advertisement

ORKA Stock Latest News

Oruka Therapeutics Shareholders Back Governance and Executive Pay
Company AnnouncementsOruka Therapeutics Shareholders Back Governance and Executive Pay
17d ago
8K
ORKA
Kapoor Reiterates Buy on Oruka Therapeutics as Pipeline Advances; Keeps $120 Price Target Unchanged
PremiumRatings
Kapoor Reiterates Buy on Oruka Therapeutics as Pipeline Advances; Keeps $120 Price Target Unchanged
19d ago
ORKA
Oruka Therapeutics Expands IL-23 License, Adds Dosing Limits
PremiumCompany Announcements
Oruka Therapeutics Expands IL-23 License, Adds Dosing Limits
20d ago
8K
ORKA
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
PremiumRatings
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
1M ago
ORKA
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
PremiumRatings
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
1M ago
ORKA
Oruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
PremiumRatingsOruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
1M ago
ORKA
Oruka Therapeutics reports Q1 EPS (48c), consensus (54c)
Premium
The Fly
Oruka Therapeutics reports Q1 EPS (48c), consensus (54c)
1M ago
ORKA
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
Premium
The Fly
Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis
2M ago
HALO
ORKA
Oruka Therapeutics Completes Public Equity Offering Under Shelf
PremiumCompany Announcements
Oruka Therapeutics Completes Public Equity Offering Under Shelf
2M ago
8K
ORKA
Oruka Therapeutics price target raised to $120 from $109 at Leerink
PremiumThe Fly
Oruka Therapeutics price target raised to $120 from $109 at Leerink
2M ago
ORKA
Oruka Therapeutics price target raised to $120 from $75 at H.C. Wainwright
PremiumThe Fly
Oruka Therapeutics price target raised to $120 from $75 at H.C. Wainwright
2M ago
ORKA
Oruka Therapeutics $700M Secondary priced at $72.50
PremiumThe Fly
Oruka Therapeutics $700M Secondary priced at $72.50
2M ago
ORKA
Oruka Therapeutics price target raised to $100 from $75 at UBS
PremiumThe FlyOruka Therapeutics price target raised to $100 from $75 at UBS
2M ago
ORKA
Oruka Therapeutics announces $500M common stock, warrants offering
Premium
The Fly
Oruka Therapeutics announces $500M common stock, warrants offering
2M ago
ORKA
Oruka Therapeutics price target raised to $131 from $71 at Clear Street
Premium
The Fly
Oruka Therapeutics price target raised to $131 from $71 at Clear Street
2M ago
ORKA
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
2M ago
AMD
DIA
Oruka Therapeutics rises 19.0%
PremiumThe Fly
Oruka Therapeutics rises 19.0%
2M ago
ORKA
Oruka Therapeutics price target raised to $160 from $78 at Barclays
PremiumThe Fly
Oruka Therapeutics price target raised to $160 from $78 at Barclays
2M ago
ORKA
Oruka Therapeutics price target raised to $165 from $85 at Wedbush
PremiumThe Fly
Oruka Therapeutics price target raised to $165 from $85 at Wedbush
2M ago
ORKA
Oruka Therapeutics price target raised to $200 from $125 at Guggenheim
PremiumThe FlyOruka Therapeutics price target raised to $200 from $125 at Guggenheim
2M ago
ORKA
Oruka Therapeutics rises 23.5%
Premium
The Fly
Oruka Therapeutics rises 23.5%
2M ago
ORKA
Oruka Therapeutics price target raised to $151 from $78 at BTIG
Premium
The Fly
Oruka Therapeutics price target raised to $151 from $78 at BTIG
2M ago
ORKA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >